Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021
PHIOW
PHIOW was delisted on the 21st of December, 2021.
4 hedge funds and large institutions have $2.08K invested in Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 in 2019 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.
33% less funds holding
Funds holding: 6 → 4 (-2)
98% less capital invested
Capital invested by funds: $103K → $2.08K (-$101K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$940 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $2K | +$940 | +32,860 | +189% |
|
|
AFM
2
Anson Funds Management
Dallas,
Texas
| $82 | – | – | – |
|
|
SM
3
Sabby Management
Miami Beach,
Florida
| – | -$5K | -194,959 | Closed |
|
PHIOW Hedge Fund Activity: Q2 2019 in Review
4 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 (PHIOW) for Q2 2019, worth a combined $2.08K — down 98% from $103K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of PHIOW and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was Susquehanna International Group, adding an estimated $940. The largest seller was Sabby Management, exiting entirely with an estimated $5K sold.
- 4 institutional investors held Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 (PHIOW) as of Q2 2019, down from 6 in Q1 2019.
- Funds reported $2.08K of Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 stock for Q2 2019, down 98% quarter-over-quarter.
- 0 funds opened new Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 positions in Q2 2019 and 2 closed out, a net change of -2 holders.
- The largest Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 buyer in Q2 2019 was Susquehanna International Group, an estimated $940 added.
- The largest Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 seller in Q2 2019 was Sabby Management, an estimated $5K sold.
Based on aggregated 13F filings for Q2 2019.